Portal de Periódicos da CAPES

PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study

2016; Elsevier BV; Volume: 127; Issue: 12 Linguagem: Inglês

10.1182/blood-2015-11-679407

1528-0020

Sally F. Barrington, Amy A. Kirkwood, Antonella Franceschetto, Michael Fulham, Thomas H. Roberts, Helén Almquist, Eva Brun, Karin Hjorthaug, Zaid Viney, Lucy Pike, Massimo Federico, Stefano Luminari, John Radford, Judith Trotman, Alexander Fosså, Leanne Berkahn, Daniel Molin, Francesco d’Amore, Donald A. R. Sinclair, Paul Smith, Michael O’Doherty, Lindsey Stevens, Peter Johnson,

Lung Cancer Treatments and Mutations

Key Points PET-CT is the modern standard for staging Hodgkin lymphoma and can replace contrast enhanced CT in the vast majority of cases. Agreement between expert and local readers is sufficient for the Deauville criteria to assess response in clinical trials and the community.